ArticleWomen's health reports (New Rochelle, N.Y.)
Menstrual Disorder Frequency Across Ibuprofen and Oral Contraceptive Treatment Modalities in Reproductive-Age Women: A Population-Based Analysis Using the NIH
Article in Women's health reports (New Rochelle, N.Y.). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Despite the widespread use of nonsteroidal anti-inflammatory drugs and oral contraceptives (OC), population-level analyses on how menstrual disorder diagnoses vary across ibuprofen and OC use remain limited. Prior studies emphasize treatment efficacy for individual conditions rather than cross-sectional diagnosis co-occurrence across these treatment categories. The NIH Methods: We conducted a retrospective cross-sectional analysis of female participants 18-35 years old using Results: In women aged 18-24 years, no significant differences in diagnosis prevalence were observed between treatment groups (ibuprofen: Conclusions: Menstrual disorder diagnosis frequencies differed across ibuprofen and OC exposure groups, primarily among women 25-35 years old. Longitudinal studies with untreated comparators and better characterizations of treatment timing, dose, and duration are needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.